Xianying Fang

Xianying Fang

Auto-generated profile, based on publicly available information

Xianying Fang

Transplantation Research Center, The Catholic University of Korea, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2025 in Kidney Research and Clinical Practice
Verified
Journal Article
Open access
PDF file
HLHanbi Lee
Hanbi Lee
YSYoo-Jin Shin
Yoo-Jin Shin
XFXianying Fang
Xianying Fang
SCSheng Cui
Sheng Cui
SLSun Woo Lim
Sun Woo Lim
BCByung Ha Chung
Byung Ha Chung
Background: The aim of this study is to investigate the specific pathway involved in human leukocyte antigen (HLA) sensitization using single-cell RNA-sequencing analysis and an allo-sensitized mouse model developed with an HLA.A2 transgenic mouse. Methods: For sensitization, wild-type C57BL/6 mouse received two skin grafts from C57BL/6-Tg(HLA-A2.1)1Enge/J mouse (allogeneic mouse, ALLO). For syngeneic control (SYN), skin grafts were transferred from C57BL/6 to C57BL/6. We performed single-cell RNA-sequencing analysis on splenocytes isolated from ALLO and SYN and compared the gene expression between them.Results: We generated 9,190 and 8,890 single-cell transcriptomes from ALLO and SYN, respectively. Five major cell types (B cells, T cells, natural killer cells, macrophages, and neutrophils) and their transcriptome data were annotated according to the representative differentially expressed genes of each cell cluster. The percentage of B cells was higher in ALLO than it was in SYN. Kyoto Encyclopedia of Genes and Genomes enrichment analyses indicated that the highly expressed genes in the B cells from ALLO were mainly associated with antigen processing and presentation pathways, allograft rejection, and the Th17 cell differentiation pathway. Upregulated genes in the T cells of ALLO were involved in the interleukin (IL)-17 signaling pathway. The ratio of Th17 cluster and Treg cluster was increased in the ALLO. On flow cytometry, the percentage of Th17 (IL-17+/CD4+ T) cells was higher and regulatory T cells (FOXP3+/CD4+ T) was lower in the ALLO compared to those in the SYN.Conclusion: Our results indicate that not only the B cell lineage but also the Th17 cells and their cytokine (IL-17) are involved in the sensitization to HLA.


6 February 2026 in Kidney Research and Clinical Practice
Verified
Journal Article
Closed access
SLSun Woo Lim
Sun Woo Lim
XFXianying Fang
Xianying Fang
SCSheng Cui
Sheng Cui
HLHanbi Lee
Hanbi Lee
DNDohyun Na
Dohyun Na
BCByung Ha Chung
Byung Ha Chung
This study aims to investigate the effects of complete SLC12A3 gene knock-in using clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) in human-induced pluripotent stem cells (hiPSCs), focusing on cellular characteristics and functional implications in the context of Gitelman syndrome. Employing CRISPR/Cas9 gene-editing technology, the SLC12A3 gene was integrated into WTC-11 hiPSCs, resulting in the creation of the WTC-11SLC12A3-KI cell line. Successful integration was confirmed through green fluorescence protein (GFP) reporter gene expression, and SLC12A3 expression was verified via polymerase chain reaction, flow cytometry, immunoblotting, and immunofluorescence in kidney organoids. Functional analysis with the intracellular sodium indicator CoroNa Green dye (Invitrogen) assessed the impact of SLC12A3 gene knock-in and thiazides. The WTC-11SLC12A3-KI hiPSCs exhibited successful integration of the SLC12A3 gene, with enhanced SLC12A3 expression evidenced by GFP and SLC12A3 proteins compared to WTC-11 hiPSCs. Upon differentiation into kidney organoids, the WTC-11SLC12A3-KI organoids displayed increased GFP, SLC12A3 expression, and the associated WNK-SPAK/OSR1 signaling cascade relative to WTC- 11 organoids. The intracellular sodium flux was stimulated by angiotensin II treatment in kidney organoid cells and attenuated by thiazides in both WTC-11 and WTC-11SLC12A3-KI groups. This study indicates that the knock-in of the SLC12A3 gene could serve as a therapeutic strategy for Gitelman syndrome.

8 October 2026 in Kidney Research and Clinical Practice
Verified
Journal Article
Open access
PDF file
DNDohyun Na
Dohyun Na
XFXianying Fang
Xianying Fang
HLHanbi Lee
Hanbi Lee
SESang Hun Eum
Sang Hun Eum
EKEun Jeong Ko
Eun Jeong Ko
BCByung Ha Chung
Byung Ha Chung
Sodium-glucose cotransporter-2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used in type 2 diabetes mellitus for glycemic control and organ protection. This study investigated whether the combined use of empagliflozin (EMPA) and liraglutide (LIRA) could protect against pancreatic and renal damage caused by tacrolimus (TAC). Male Sprague-Dawley rats received TAC for 4 weeks, either alone, or in combination with EMPA, LIRA, or both. Metabolic, histologic, and molecular parameters were assessed in vivo and in vitro. TAC caused hyperglycemia, reduced creatinine clearance, pancreatic β-cell loss, renal tubulointerstitial fibrosis, and increased oxidative stress and apoptosis. Either EMPA or LIRA alone partially attenuated these changes, whereas their combination provided enhanced protection- improving kidney function, preserving islet integrity, and reducing fibrosis and cell death. In the kidney and pancreas, dual therapy restored antiapoptotic and antioxidant signaling while suppressing profibrotic pathways, thereby mitigating oxidative stress and injury. Cell-based experiments further confirmed that EMPA plus LIRA enhanced cell viability and reduced reactive oxygen species generation in TAC-injured HK-2 and INS-1 cells. These findings indicate that combined SGLT2i and GLP-1RA therapy confers additive metabolic protection associated with attenuation of oxidative stress in tacrolimus-induced pancreatic and renal damage in this preclinical model, warranting further investigation of its potential as an adjunct strategy for posttransplant diabetes mellitus and nephrotoxicity.

30 June 2026 in Kidney Research and Clinical Practice
Verified
Journal Article
Open access
PDF file
YSYoo Jin Shin
Yoo Jin Shin
XFXianying Fang
Xianying Fang
HLHanbi Lee
Hanbi Lee
DNDohyun Na
Dohyun Na
SLSun Woo Lim
Sun Woo Lim
BCByung Ha Chung
Byung Ha Chung
X-linked Alport syndrome (XLAS) is an inherited nephropathy caused by pathogenic COL4A5 variants that lead to podocyte dysfunction and progressive kidney failure. However, the involvement of endoplasmic reticulum (ER) stress and oxidative stress in the development of XLAS remains insufficiently understood. This study aims to elucidate the contribution of ER and oxidative stress to podocyte injury in XLAS employing a patient-derived human induced pluripotent stem cell (hiPSC)-based podocyte model. Induced pluripotent stem cells were derived from XLAS patient blood cells and differentiated into podocytes (XLAS podocyte). Expression of pluripotency, lineage-specific, and podocyte markers was confirmed. ER stress, oxidative stress, and mitochondrial morphology were assessed through molecular characterization, imaging, and functional assays, comparing XLAS podocytes to wild-type (WT) hiPSC-derived podocytes. XLAS patient-derived hiPSCs maintained typical pluripotency markers, exhibited normal karyotypes, and allowed for successful tri-lineage differentiation. Relative to WT podocytes, XLAS podocytes had diminished expression of NPHS1, WT1, and COL4A5, while COL4A1 was increased. ER stress marker expression was elevated, with lower levels of CANX and CALR, indicative of unfolded protein response (UPR) activation. Electron microscopy analysis demonstrated enhanced ER enlargement in XLAS podocyte, implicating ER stress in disease pathogenesis. Moreover, XLAS podocytes showed markedly raised oxidative stress markers and mitochondrial reactive oxygen species (ROS) levels, together with altered catalase protein expression. Viability assays further supported ER and oxidative stress as contributors to reduced podocyte survival in XLAS podocyte. Our findings indicate that ER stress and oxidative stress are critical drivers of podocyte dysfunction in XLAS. UPR activation, ROS accrual, and mitochondrial impairment point to important therapeutic opportunities.